Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 16:32:06 UTC |
---|
Update Date | 2021-09-26 23:11:42 UTC |
---|
HMDB ID | HMDB0256210 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Pelitinib |
---|
Description | N-{4-[(3-chloro-4-fluorophenyl)imino]-3-cyano-7-ethoxy-1,4-dihydroquinolin-6-yl}-4-(dimethylamino)but-2-enimidic acid belongs to the class of organic compounds known as 4-aminoquinolines. These are organic compounds containing an amino group attached to the 4-position of a quinoline ring system. Based on a literature review very few articles have been published on N-{4-[(3-chloro-4-fluorophenyl)imino]-3-cyano-7-ethoxy-1,4-dihydroquinolin-6-yl}-4-(dimethylamino)but-2-enimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Pelitinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Pelitinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCOC1=C(NC(=O)C=CCN(C)C)C=C2C(NC3=CC(Cl)=C(F)C=C3)=C(C=NC2=C1)C#N InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32) |
---|
Synonyms | Value | Source |
---|
N-{4-[(3-chloro-4-fluorophenyl)imino]-3-cyano-7-ethoxy-1,4-dihydroquinolin-6-yl}-4-(dimethylamino)but-2-enimidate | Generator |
|
---|
Chemical Formula | C24H23ClFN5O2 |
---|
Average Molecular Weight | 467.93 |
---|
Monoisotopic Molecular Weight | 467.1524309 |
---|
IUPAC Name | N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide |
---|
Traditional Name | N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC1=C(NC(=O)C=CCN(C)C)C=C2C(NC3=CC(Cl)=C(F)C=C3)=C(C=NC2=C1)C#N |
---|
InChI Identifier | InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32) |
---|
InChI Key | WVUNYSQLFKLYNI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 4-aminoquinolines. These are organic compounds containing an amino group attached to the 4-position of a quinoline ring system. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Aminoquinolines and derivatives |
---|
Direct Parent | 4-aminoquinolines |
---|
Alternative Parents | |
---|
Substituents | - 4-aminoquinoline
- Aniline or substituted anilines
- N-arylamide
- Alkyl aryl ether
- Fluorobenzene
- Aminopyridine
- Halobenzene
- Chlorobenzene
- Aryl chloride
- Aryl fluoride
- Benzenoid
- Monocyclic benzene moiety
- Aryl halide
- Pyridine
- Heteroaromatic compound
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxamide group
- Tertiary amine
- Secondary carboxylic acid amide
- Ether
- Carboxylic acid derivative
- Azacycle
- Carbonitrile
- Nitrile
- Secondary amine
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Organofluoride
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 211.174 | 30932474 | DeepCCS | [M-H]- | 208.816 | 30932474 | DeepCCS | [M-2H]- | 241.701 | 30932474 | DeepCCS | [M+Na]+ | 217.267 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pelitinib,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 3841.4 | Semi standard non polar | 33892256 | Pelitinib,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 3402.3 | Standard non polar | 33892256 | Pelitinib,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 5056.5 | Standard polar | 33892256 | Pelitinib,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 3923.8 | Semi standard non polar | 33892256 | Pelitinib,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 3272.4 | Standard non polar | 33892256 | Pelitinib,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 5048.6 | Standard polar | 33892256 | Pelitinib,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 3576.1 | Semi standard non polar | 33892256 | Pelitinib,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 3126.9 | Standard non polar | 33892256 | Pelitinib,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C | 4578.6 | Standard polar | 33892256 | Pelitinib,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 4017.7 | Semi standard non polar | 33892256 | Pelitinib,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 3576.9 | Standard non polar | 33892256 | Pelitinib,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(F)C(Cl)=C3)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 5038.3 | Standard polar | 33892256 | Pelitinib,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 4116.1 | Semi standard non polar | 33892256 | Pelitinib,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 3401.8 | Standard non polar | 33892256 | Pelitinib,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NC(=O)C=CCN(C)C | 5041.5 | Standard polar | 33892256 | Pelitinib,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 3929.0 | Semi standard non polar | 33892256 | Pelitinib,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 3423.1 | Standard non polar | 33892256 | Pelitinib,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(C(=O)C=CCN(C)C)[Si](C)(C)C(C)(C)C | 4627.1 | Standard polar | 33892256 |
|
---|